ampelopsin has been researched along with angiotensin ii in 1 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (angiotensin ii) | Trials (angiotensin ii) | Recent Studies (post-2010) (angiotensin ii) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 38,152 | 1,089 | 7,413 |
| Protein | Taxonomy | ampelopsin (IC50) | angiotensin ii (IC50) |
|---|---|---|---|
| Atrial natriuretic peptide receptor 3 | Homo sapiens (human) | 0.002 | |
| Type-1A angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.002 | |
| Type-1B angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.0018 | |
| Type-1 angiotensin II receptor | Homo sapiens (human) | 0.0055 | |
| Type-2 angiotensin II receptor | Rattus norvegicus (Norway rat) | 0.004 | |
| Type-2 angiotensin II receptor | Homo sapiens (human) | 0.0011 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Meng, G; Yang, S; Yao, W; Zhang, W; Zhu, H | 1 |
1 other study(ies) available for ampelopsin and angiotensin ii
| Article | Year |
|---|---|
Attenuating effects of dihydromyricetin on angiotensin II-induced rat cardiomyocyte hypertrophy related to antioxidative activity in a NO-dependent manner.
Topics: Angiotensin II; Animals; Animals, Newborn; Antioxidants; Cell Size; Cell Survival; Cyclic GMP; Flavonols; Mitogen-Activated Protein Kinases; Myocytes, Cardiac; Nitric Oxide; Nitric Oxide Synthase Type III; Primary Cell Culture; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2015 |